Details of the Drug
General Information of Drug (ID: DM3ALJD)
Drug Name |
(Z)-5-Benzylidene-2-thioxothiazolidin-4-one
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
5-Benzylidenrodanin; 5-Benzylidenerhodanine; Rhodanine, 5-benzylidene-; NSC 43398; 5-Benzylidene-2-thioxo-4-thiazolidinone; CHEMBL305763; 5-(Phenylmethylene)-2-thioxo-4-thiazolidinone; (5Z)-5-benzylidene-2-sulfanyl-1,3-thiazol-4(5H)-one; 4-Thiazolidinone, 5-(phenylmethylene)-2-thioxo-; 3806-42-6; MLS002608541; 5-Benzyliden-rhodanin; AC1LOXMG; Rhodanine, 5-benzylidene; (Z)-5-Benzylidene-2-thioxothiazolidin-4-one; SCHEMBL3491175; MolPort-001-579-311; MolPort-000-420-057; HMS3087E14; HMS1786A04; ZINC1088586; 174813-23-1; STK441367
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 221.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||